PAPER Ryan SD, Dolatabadi N, Chan SF, Zhang X, Akhtar MW, Parker J, Soldner F, Sunico CR, Nagar S, Talantova M, Lee B, Lopez K, Nutter A, Shan B, Molokanova E, Zhang Y, Han X, Nakamura T, Masliah E, Yates JR 3rd, Nakanishi N, Andreyev AY, Okamoto S, Jaenisch R, Ambasudhan R, Lipton SA
SEARCH RESULTS
329940 RESULTS
PAPER Tanaka S, Ishii A, Ohtaki H, Shioda S, Yoshida T, Numazawa S
Activation of microglia induces symptoms of Parkinson's disease in wild-type, but not in IL-1 knockout mice.
J Neuroinflammation. 2013 Dec 1;10:143. PubMed: 24289537PAPER Pyo JH, Jeong YK, Yeo S, Lee JH, Jeong MY, Kim SH, Choi YG, Lim S
Neuroprotective effect of trans-cinnamaldehyde on the 6-hydroxydopamine-induced dopaminergic injury.
Biol Pharm Bull. 2013;36(12):1928-35. PubMed: 24292051PAPER Singh MD, Raj K, Sarkar S
Drosophila Myc, a novel modifier suppresses the poly(Q) toxicity by modulating the level of CREB binding protein and histone acetylation.
Neurobiol Dis. 2014 Mar;63:48-61. Epub 2013 Nov 27 PubMed: 24291519PAPER Asahina M
[Cognitive function and blood pressure regulation in Lewy body diseases].
Rinsho Shinkeigaku. 2013;53(11):1386-8. PubMed: 24291999PAPER Bogousslavsky J, Paciaroni M
Parkinsonism in poets and writers.
Prog Brain Res. 2013;206:59-71. PubMed: 24290476PAPER Yue X, Hariri DJ, Caballero B, Zhang S, Bartlett MJ, Kaut O, Mount DW, Wüllner U, Sherman SJ, Falk T
Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
Neuroscience. 2014 Jan 31;258:385-400. Epub 2013 Nov 27 PubMed: 24291725PAPER Onodera O
[Molecular pathogenesis of ALS in TDP43 era].
Rinsho Shinkeigaku. 2013;53(11):1077-9. PubMed: 24291884PAPER Takashima A
[Present and future of the tau dementia therapy].
Rinsho Shinkeigaku. 2013;53(11):1040-2. PubMed: 24291873PAPER Kar K, Arduini I, Drombosky KW, van der Wel PC, Wetzel R
D-polyglutamine amyloid recruits L-polyglutamine monomers and kills cells.
J Mol Biol. 2014 Feb 20;426(4):816-29. Epub 2013 Nov 28 PubMed: 24291210PAPER Egawa N, Inoue H
[ALS disease modeling and drug screening using patient-specific iPS cells].
Rinsho Shinkeigaku. 2013;53(11):1020-2. PubMed: 24291866PAPER Yabe I, Sasaki H
[Chromosomal structural variation-- an approach for multiple system atrophy].
Rinsho Shinkeigaku. 2013;53(11):1333-5. PubMed: 24291978PAPER Mitsui J
[Toward identification of susceptible genes for sporadic neurodegenerative disease].
Rinsho Shinkeigaku. 2013;53(11):1336-8. PubMed: 24291979PAPER Chiu WH, Carlsson T, Depboylu C, Höglinger GU, Oertel WH, Ries V
Selegiline normalizes, while l-DOPA sustains the increased number of dopamine neurons in the olfactory bulb in a 6-OHDA mouse model of Parkinson's disease.
Neuropharmacology. 2014 Apr;79:212-21. Epub 2013 Nov 28 PubMed: 24291466PAPER Iovino M, Pfisterer U, Holton JL, Lashley T, Swingler RJ, Calo L, Treacy R, Revesz T, Parmar M, Goedert M, Muqit MM, Spillantini MG
The novel MAPT mutation K298E: mechanisms of mutant tau toxicity, brain pathology and tau expression in induced fibroblast-derived neurons.
Acta Neuropathol. 2014 Feb;127(2):283-95. Epub 2013 Nov 30 PubMed: 24292008Current Filters
No filters selected